<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title>Gambling With Speculative Healthcare Stocks - Seeking Alpha</title>
<meta http-equiv="X-UA-Compatible" content="IE=7" />
<meta http-equiv="Content-Type" content="text/html;charset=utf-8" />
<meta http-equiv="P3P" content='CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"' />
<link rel="search" type="application/opensearchdescription+xml" href="/javascripts/seeking.xml" title="SeekingAlpha Search" />


<meta name="original-source" content="http://seekingalpha.com/article/291745-gambling-with-speculative-healthcare-stocks">
<link href="http://static.seekingalpha.com/stylesheets/print.css?1310882701" media="print" rel="stylesheet" type="text/css" />

<link rel="shortcut icon" type="image/ico" href="http://static.seekingalpha.com/favicon.ico" />
<link rel="canonical" href="http://seekingalpha.com/article/291745-gambling-with-speculative-healthcare-stocks" />

<link href="http://static.seekingalpha.com/stylesheets/performance_layout_packaged.css?1314525586" media="screen" rel="stylesheet" type="text/css" />







<link href="http://static.seekingalpha.com/stylesheets/article_packaged.css?1314525590" media="screen" rel="stylesheet" type="text/css" />
<script type="text/javascript">
  var users_on_site='807,051';
	var has_etf_changed_hash = {}; 
  var user_cookie={};

  function readCookie(name) {
    var cookie = document.cookie.match(new RegExp('(^|;)\\s*' + escape(name) + '=([^;\\s]*)'));
    return (cookie ? unescape(cookie[2]) : null);
  }

  function addToCookie(key,value) {
    var arr=user_cookie[key].split(',');
    arr.push(value);

    user_cookie[key]=arr.join(',');
  }

  if (readCookie('user_cookie_key')) {
    document.write('<scr'+'ipt src="http://static.seekingalpha.com/account/cookie/'+readCookie('user_cookie_key')+'"></scri'+'pt>');
  } else if (readCookie('user_id')) {
    document.write('<scr'+'ipt src="http://seekingalpha.com/account/no_cookie_key"></scri'+'pt>');
  }

  var quantSegs="";
  function qc_results(result) {
    for (var i = 0; i < result.segments.length; i++) {
      quantSegs += "qc=" + result.segments[i].id + ";";
    }
  }

  var _sf_startpt=(new Date()).getTime();
</script>
<script type="text/javascript" src="http://pixel.quantserve.com/api/segments.json?a=p-36Zq38JCUmc3w&callback=qc_results"></script>

<script src="http://static.seekingalpha.com/javascripts/common_article_packaged.js?1314525570" type="text/javascript"></script>



<script src="http://partner.googleadservices.com/gampad/google_service.js" type="text/javascript"></script>



<script type="text/javascript">
  if (typeof(is_users_cookie_exists) == "function" && is_users_cookie_exists() && readCookie('user_email').indexOf('@gmail.com')!=-1) {
    createCookie('user_email',(readCookie('user_email').replace('@gmail.com','').replace(/\./gi,'').replace(/\+(.*?)$/,''))+'@gmail.com',365)
  }

  if (typeof(readCookie) == "function" && readCookie('user_vocation')) {
    createCookie('u_voc',readCookie('user_vocation'),3000);
  }

  var user_cookie = user_cookie || {};

  <!-- ClickTale Top part -->
  var WRInitTime=(new Date()).getTime();
  <!-- ClickTale end of Top part -->

  var _comscore = _comscore || [];
  _comscore.push({ c1: "2", c2: "8500672" });
  (function() {
    var s = document.createElement("script"), el = document.getElementsByTagName("script")[0]; s.async = true;
    s.src = (document.location.protocol == "https:" ? "https://sb" : "http://b") + ".scorecardresearch.com/beacon.js";
    el.parentNode.insertBefore(s, el);
  })();

  var _sf_startpt=(new Date()).getTime(); // chartbeat code
if (typeof(initAds) == 'function'){
var delayInit = null;
Event.stopObserving(window,'scroll',initAds);
function initAds2() {
  clearTimeout(delayInit);
  delayInit = setTimeout(initAdsDelay,400);
}

function initAdsDelay(){
  if (adInfo && !adInfo.HadCreated) {
    var el = $("article_dart_sticky");
    if (el){
      if (ScrollerCloseToElement(el,200)){
       adInfo.HadCreated = true;
       createIframeAdInEl($("article_dart_sticky"),adInfo.size,adInfo.info);
       if(!(/.*\/comments$/.test(location.pathname))){ 
         var ad = new stickyAd(el.id,{Height:250});
         ad.fixed_ads_init();
        }
      }
    }
  }
}

function ScrollerCloseToElement(el,delta) {
  var ep_y = Element.positionedOffset(el)[1];
  var vp_y = document.viewport.getScrollOffsets().top;
  var viewport = document.viewport.getDimensions();
  return (ep_y < vp_y + viewport.height + delta)
}
Event.observe(window,"scroll",initAds2);
}
function createIframeAdInEl(el, sizeXformat, src){
  if (/\/shark\//i.test(location)) { // don't display ad in shark preview
    return "";
  }
  var sizeParts = sizeXformat.split("x")
  var query=[];
  if (window.ms_slug) query.push("ms_slug="+window.ms_slug);
  if (window.article_dashboards) query.push("article_dashboards="+window.article_dashboards);
  if (window.article_sectors_themes)  query.push("article_sectors_themes="+window.article_sectors_themes);
  var iframeFilePath = "";
  if (location.host == "seekingalpha.com") {
    iframeFilePath = "http://static.seekingalpha.com";
  } else if (location.host == "staging.seekingalpha.com") {
    iframeFilePath = "http://static-staging.seekingalpha.com";
  }
  var iframe = document.createElement("iframe");
  iframe.scrolling = "no";
  iframe.height=sizeParts[1];
  iframe.width=sizeParts[0];
  iframe.marginWidth = "0";
  iframe.marginHeight = "0";
  iframe.frameBorder = "0";
  iframe.vspace = 0;
  iframe.hspace = 0;
  iframe.style.border = "0px none";
  iframe.src=iframeFilePath+'/adsframe.html#que='+encodeURIComponent(src)+(query.length ? ("&par="+encodeURIComponent(query.join("&"))) : "");
  el.appendChild(iframe);
}
</script>

<style>
#main_container.front {
  min-height:800px;
}
</style>

<noscript>
  <img src="http://b.scorecardresearch.com/p?c1=2&c2=8500672&cv=2.0&cj=1" />
</noscript>


<script type="text/javascript" src="/javascripts/refaeli.js"></script>
    
<script type="text/javascript">
  GS_googleAddAdSenseService("ca-pub-1420150919334552");
  GS_googleEnableAllServices();
</script>
<script type="text/javascript">
      GA_googleAddSlot_sa("Article_120x30");
  </script>
<script type="text/javascript">
  GA_googleFetchAds();
</script>
  </head>
  
  
    <body class="stretch_bg">
  
  
    <div id="floating_bar" >
      <div class="floating_logged_in" id="floating_logged_in" style="display:none;"></div>
      <div class="floating_logged_out" id="floating_logged_out">
        <ul>
          <li class="logout_wording">See the difference! Customize Seeking Alpha: <span onmouseout="link_out(this, '#024999')" onmouseover="link_over(this, '#024999')" onclick="open_header_log_in_popup_lightbox('login','');" style="color:#024999 !important;">Sign in or join</span></li>
          <li class="floating_sa_logo_li"><a class="floating_sa_logo_a" href="/"></a></li>
        </ul>
      </div>
    </div>
    
    <script>
  var ms_slug = '';
  var article_dashboards = '@investing-ideas@';
  var article_sectors_themes = '@quick-picks-lists@sa-exclusive@';
  var news_beat_author = 'Michael J. Ray';
  var news_beat_sections = "article";
  var ratings_hash={};
</script>

<script>var mone_article_tags = "{aezs,ttnp.ob,rxii,nvax,mnkd,gern};;;{};;;{quick-picks-lists};;;{michael-j-ray}"</script>

 <script>var ord = Math.floor(Math.random()*1000000000);</script>
<span class="seeking_alpha_site_title">Seeking Alpha</span>
<script type="text/javascript">
if (readCookie('sa_mobile') == '0'){
var aHTML =[];
aHTML.push('<div class="mobile_or_full_site">');
aHTML.push('<span class="mobile_site" onclick="createCookie(\'sa_mobile\',1,1000);top.location.reload()">Click here to view mobile site</span>');
aHTML.push('<div class="cleaner"></div>');
aHTML.push('</div>');
document.write(aHTML.join(""));
}
</script>
<div id="header" class="not_logged_in header_nav">
  <div id="logo_and_navigation" class="logo_and_primary_navigation">
    
<div id="comment_popup" style="position:relative; left:0; display:none">
  <div id="popup_secondary">
    <div id="inner_popup"></div>
  </div>
</div>
    <h1><a href="/" title="Seeking Alpha - Home Page" sasource="salogo"></a></h1>
    <div class="item banner728x90">
      
      
        <script type="text/javascript">
          iframeAd("728x90",'http://a.collective-media.net/adj/sek.target/article;sz=728x90;x=x;tile=1;d=target;t=article;d=investing-ideas;aid=291745;t=quick-picks-lists;t=sa-exclusive;a=michael-j-ray;s=aezs;s=ttnp.ob;s=rxii;s=nvax;s=mnkd;s=gern;'+dart_my_vocation_and_profiles()+'ord='+ord+'?"');
        </script>
      
    </div>
  </div>
  <div id="nav_container">
    <div id="navi_cont">
	<ul id="navi">
    <li class="home" onmouseover="addThisClass(this,'yes_selected_not_new');" onmouseout="removeThisClass(this,'yes_selected_not_new');">
		  <a href="/" sasource="headtabs">Home</a>
		  <span class="navi_right_corner">|</span>
		</li>
		<li class="portfolios " onmouseover="addThisClass(this,'yes_selected_not_new');" onmouseout="removeThisClass(this,'yes_selected_not_new');">
		  <a href="/account/portfolio" sasource="headtabs">Portfolio</a>
		  <span class="navi_right_corner">|</span>
		</li>
		<li  onmouseover="addThisClass(this,'yes_selected_not_new');" onmouseout="removeThisClass(this,'yes_selected_not_new');">
		  <a href="/currents/all" sasource="headtabs">Market Currents</a>
		  <span class="navi_right_corner">|</span>
		</li>
		<li  onmouseover="addThisClass(this,'yes_selected_not_new');" onmouseout="removeThisClass(this,'yes_selected_not_new');">
		  <a href="/dashboard/investing_ideas" sasource="headtabs">Long &amp; Short Ideas</a>
		  <span class="navi_right_corner">|</span>
		</li>
		<li  onmouseover="addThisClass(this,'yes_selected_not_new');" onmouseout="removeThisClass(this,'yes_selected_not_new');">
		  <a href="/dashboard/investing_income" sasource="headtabs">Investing for Income</a>
		  <span class="navi_right_corner">|</span>
		</li>
		<li  onmouseover="addThisClass(this,'yes_selected_not_new');" onmouseout="removeThisClass(this,'yes_selected_not_new');">
		  <a href="/dashboard/etfs" sasource="headtabs">ETFs &amp; Portfolio Strategy</a>
		  <span class="navi_right_corner">|</span>
		</li>
		<li  onmouseover="addThisClass(this,'yes_selected_not_new');" onmouseout="removeThisClass(this,'yes_selected_not_new');">
		  <a href="/dashboard/macro_view" sasource="headtabs">Macro View</a>
		  <span class="navi_right_corner">|</span>
		</li>
    <li  onmouseover="addThisClass(this,'yes_selected_not_new');" onmouseout="removeThisClass(this,'yes_selected_not_new');">
      <a href="/tag/transcripts" sasource="headtabs">Earnings</a>
    </li>
    <li id="user_settings_wrapper"></li>
    <script type="text/javascript">
      var aHtml=[];
      if (is_users_cookie_exists()) {
        var user_id = readCookie('user_id');
        var user_nick = readCookie('user_nick');
        if (user_nick == null || user_nick == "") user_nick = "User " + user_id;
        var profile_href = (readCookie('author_slug')==null || readCookie('author_slug')=='') ? "/user/"+user_id+"/profile" : "/author/"+readCookie('author_slug');

        aHtml.push('<div class="user_settings" id="user_settings">');
          aHtml.push('<span class="user_image"><img src="' + user_picture(user_id,'small') + '" /></span>');
          aHtml.push('<span id="top_nav_arrow" class="top_nav_arrow_down" style="cursor:pointer;">'+(user_nick.length < 11 ? user_nick : user_nick.slice(0,8)+"...")+'</span>');
          aHtml.push('<div class="user_settings_pop" id="user_settings_pop" onmouseover="show_item(\'user_settings_pop\');$(\'user_settings\').addClassName(\'up\')" style="display:none">');
            aHtml.push('<ul>');
              aHtml.push('<li><a href="'+profile_href+'" onclick="trackLink(this,\'Menu Tracking\',\'Profile\',location.href);">Profile</a></li>');
              aHtml.push('<li><a href="/account/email_preferences" onclick="trackLink(this,\'Menu Tracking\',\'My Settings\',location.href);">Settings</a></li>');
              aHtml.push('<li><a href="/store/my-applications" onclick="trackLink(this,\'Menu Tracking\',\'My Tools\',location.href);">Tools</a></li>');
              aHtml.push('<li class="sign_out"><span onmouseover="link_over(this,\'#ff0000\')" onmouseout="link_out(this,\'#024999\')" onclick="trackLink(this,\'Menu Tracking\',\'Sign out\',location.href);logout();" class="logout_link">Sign Out</span></li>');
            aHtml.push('</ul>');
          aHtml.push('</div>');
        aHtml.push('</div>');
      } else {
        aHtml.push('<span style="cursor:pointer;" onclick="open_header_log_in_popup_lightbox(\'headtabs_login\',\'\'); return false">Sign in / Join Now</span>');
      }
      $('user_settings_wrapper').innerHTML=aHtml.join("");
    </script>
  </ul>
</div>

  </div>
  <script type="text/javascript">
    if (/msie 6/i.test(navigator.userAgent)) document.write("<div class='ie_obsolete_message'>You are using outdated version of Internet Explorer which may distort the way you see certain areas of the site. You can <a href='http://www.microsoft.com/windows/internet-explorer/worldwide-sites.aspx' onclick='pageTracker._trackEvent(\"IE Upgrade\",\"Click\");'>upgrade Internet Explorer here</a>.</div><div class='ie_obsolete_line'></div><div class='cleaner'></div>");
    SeekingAlpha.Initializer.LogAndRun(set_login_and_registration_top_header);
    SeekingAlpha.Initializer.LogAndRun(InitSASource);
  </script>
</div>
 <div id="main_container" class="white_as_before">
  <div id="content_wrapper" class="article_pages">
    <img src="http://static.seekingalpha.com/images/universal/print_logo.png" id="print_seekingalpha_logo" />
    <div class="page_top">
      <div class="search_box_container_isolated">
  <div class="search_box">
    <form id="search_box_sa_search" method="get" class="linktosym comp search" action="/search/" onsubmit="return false;">
      <fieldset>
        <input id="autocomplete_sa_search" class="input_text text" type="text" value="search by symbol, author, keyword..." size="25" autocomplete="off" onblur="this.style.color=this.value=='' ? '#8D8D8D' : '#000000';handleInput(this,'blur')" onfocus="this.style.color='#000000';handleInput(this,'focus')" afteruploadvalue='eFind quotes, people, expressions, transcripts' title='search by symbol, author, keyword...' class="find_transcripts" />
        <input type="button" class="search_button" value="" onclick="if ($('autocomplete_sa_search').value!=$('autocomplete_sa_search').title) AutoCompleteSAConfig.Packages.search.Find()" />
      </fieldset>
      <input type="hidden" name="source" value="search_general" />
      <input type="hidden" id="autocomplete_sa_hidden_search" name="q" value="" />
      <input type="hidden" name="cx" value="001514237567335583750:cdhc2yeo2ko" />
      <input type="hidden" name="cof" value="FORID:11;NB:1" />
      <input type="hidden" name="goto_search_tab" value="" />
    </form>
    <script type="text/javascript">SeekingAlpha.Initializer.LogAndRun(function () { AutoCompleteSAConfig.Load('search', { Symbols:true, IframeCover:true, AfterInsert:function () { this.Find(); }, AfterSubmit:function () { this.Find(); }}) });</script>
    <script type="text/javascript" src="http://www.google.com/coop/cse/brand?form=searchbox_001514237567335583750%3Acdhc2yeo2ko&lang=en"></script>
  </div>
</div>
      <div id="page_header">
  <h1>
    <span >Gambling With Speculative Healthcare Stocks</span>
    
  </h1>
  <div id="article_info">
		<div class="article_info_pos">
			
    	<span id="page_position"></span>
	    <span class="author_name_for_print">
				
	        by: Michael J. Ray
	      
	    </span>
	    <span>September  6, 2011</span>
	    
        
	      &nbsp;|&nbsp;
	      
	      includes: <span id='about_stocks'><a href="/symbol/aezs" title='AEterna Zentaris, Inc.' sasource='article_about'>AEZS</a>, <a href="/symbol/gern" title='Geron Corporation' sasource='article_about'>GERN</a>, <a href="/symbol/mnkd" title='MannKind Corporation' sasource='article_about'>MNKD</a>, <a href="/symbol/nvax" title='Novavax, Inc.' sasource='article_about'>NVAX</a>, <a href="/symbol/rxii" title='RXi Pharmaceuticals Corporation' sasource='article_about'>RXII</a>, <a href="/symbol/ttnp.ob" title='Titan Pharmaceuticals Inc.' sasource='article_about'>TTNP.OB</a></span>
			
		</div>

		
    &nbsp;&nbsp;&nbsp;
  </div>
</div>
    </div>
    <div class="cleaner"></div>
    <div id="main_content" class="no_big_gaps_main_content">
      <ul id="page_toolbar">
  
  
  <li class="font_size">
    <div>Font Size: </div>
    <a id="article-size-small" class="small_selected" href="javascript:setArticleFont('small');"></a>
    <a id="article-size-medium" class="medium" href="javascript:setArticleFont('medium');"></a>
    <a id="article-size-large" class="large" href="javascript:setArticleFont('large');"></a>
  </li>
  <li onclick="print_article('with_comments')" class="print">
  <div class="text" onmouseover="this.style.textDecoration='underline'" onmouseout="this.style.textDecoration='none'">Print</div>
  </li>
  <li class="email">
    <span class="text" onmouseover="this.style.textDecoration='underline'" onmouseout="this.style.textDecoration='none'" onclick="email_story_to_friends('Article',291745,'http://seekingalpha.com/article/291745-gambling-with-speculative-healthcare-stocks')">Email</span>
  </li>


	<li class="share_this_page_article_toolbar">
		<div class="recommend_link" onclick="pop_recommendation('/article/291745-gambling-with-speculative-healthcare-stocks', true, 291745, 1, 'default')">
	Recommend
</div>
<div class="recommend_num" onclick="pop_recommendation('/article/291745-gambling-with-speculative-healthcare-stocks', true, 291745, 1, 'default')">
	<span class="recommends_box text">0</span>
	<span class="right_close"></span>
</div>
		

<div class="share_this_page_snippet">
  <h6>Share this page</h6>
  <div class="widgets">
    
    <!-- facebook -->
    <span class="facebook_small"><a class="fb_link_button_count" name="fb_share" type="button_count" href="http://www.facebook.com/sharer.php" onclick="open_facebook()"><span class="share_text_fb">Share</span></a></span>
    <script>SeekingAlpha.Initializer.AddAfterLoad(init_facebook);</script>
    
      <span id="linkedin_1" class="linkedin_small"><script type="IN/Share" data-counter="right"></script></span>
      <script>SeekingAlpha.Initializer.AddAfterLoad(init_linkedin);</script>
    
    <!-- twitter -->
    <span class="twitter_small">
    <script type="text/javascript">tweetmeme_style = 'compact';</script>
    <script>
      twittememeFrame(window.tweetmeme_style== "compact" ? "85x20": "50x61");
    </script>
    </span>
  </div>
  
</div>
	</li>
</ul>

      <div id="article_body_container" class="no_big_gaps_article_body_container" style="float:right;">

        <div id="article_body">
          <p>Investing in speculative biopharm healthcare stocks has often been compared to pure gambling.  I do not agree with this comparison because with gambling, often the outcome is left up to pure chance.  In speculative healthcare stocks, whether a stock is successful or not is based upon much more random chance, although sometimes it feels like that.  Investors can do their own research and make informed decisions, thereby hopefully increasing their odds of picking winning stocks.  That being the case, there are some similarities between gambling and speculative stock picking and it falls into the realms of how the bets are placed.    </p><p>Roulette is a relatively simple game where we have a table with 38 numbers on it with a small ball and wheel that is used to pick these numbers.  Those numbers go from 1-36 and a &quot;0&quot; and &quot;00&quot; for a total of the 38.  There are all kinds of bets one can make, but let's focus on just two types of bets I've observed.  The first bet is when Gambler X places a $10 bet on the number 26 with no other bets.  If the spin of the wheel lands on the number 26, Gambler X will win big based upon the payout odds. If any other number comes up, X  will lose his entire $10 bet.  Our next person, Gambler Y, had a different strategy where she also makes a $10 bet but puts $1 on each number between 1-10.  Gambler Y was betting on a basket of numbers to increase the chance to win on the next spin.  This basket approach to betting is what speculative healthcare stock investors could learn from. </p><p>One can quickly see how the basket bet can be applied to trading.  For example, X would be equivalent to the investor who takes her whole designated bankroll and invests it in just one speculative stock and hopes for the big payout.  The risk is that the company could fail in its mission and wipe out the investor's bet.  Y's betting philosophy would have an investor holding a basket of securities where one might have six to 10 highly speculative healthcare stocks.  This is where the similarities end though, because unlike Gambler Y, who will at best lose nine out of the 10 bets she placed, the investor's stock picks each have an equal chance of coming out on the winning side of the trade.  For example, if one held seven speculative healthcare stocks in one's basket and only three of them were successful, then the gains of those winning positions should more than outweigh the losses of the other four. One will have to pick stocks that are riskier in nature so that the upside potential is large enough to cover the losses that will be experienced elsewhere. </p><p>This concept takes some getting used to at first.  As the stocks are chosen and purchased, they do not appear in the &quot;basket form&quot; but as any other holding on one's statement of account.  It is easy for an investor to quickly forget the basket concept and start to spend inordinate amounts of time on each holding and trade around the position individually.  I am not saying that each holding in the basket should not be reviewed from time to time, but one has to remember to view the basket as the investment.  It is easy to forget this as speculative healthcare stocks can and will be quite volatile.  One day they can suffer steep losses only to retake those losses and post outsized gains on the next day.  That being the concept, let's put together a sample basket and see what stocks might be a good fit for investors.</p><p>&AElig;terna Zentaris Inc. (<a href="http://seekingalpha.com/symbol/aezs?source=search_general&amp;s=aezs">AEZS</a>) is a great candidate for our biopharm basket.  AEZS is a Canadian late-stage oncology drug development company currently investigating potential treatments for various cancers including colorectal, multiple myeloma, endometrial, ovarian, and prostate/bladder cancer.  The company already has one product on the market, Cetrotide, which is administered to women to prevent premature ovulation in order to increase fertility success rate. So far the revenues are derived primarily from sales and royalties from Cetrotide which amounted to $6.1 million and $13.2 million for the three-month and six-month periods ended June 30, respectively, as compared to $5.2 million and $10.9 million for the same periods in 2010. This is a nice figure but will in no way lead the share price higher to the levels we need for the basket.  For that, AZES will depend upon its drug Perifosine.  This drug is designed to treat cancers and rights have been licensed to Keryx BioPharmaceuticals (<a href="http://seekingalpha.com/symbol/kerx?source=search_general&amp;s=kerx">KERX</a>) for North America, Yakult Honsha (<a href='http://seekingalpha.com/symbol/ykltf.pk' title='Yakult Honsha Co Ltd'>YKLTF.PK</a>) for Japan and to Handok for Korea. &AElig;terna Zentaris holds the rest of the world rights.  Multiple trials are currently underway.  One of the Phase 3 trials dealing with the colorectal cancer aspect is set to have its primary completion date by December and the study is set to be completed by February 2012. Perifosine&rsquo;s second Phase 3 study, dealing with multiple myelomas, does not have its primary completion date until September 2012 and a study completion date of October 2012. In addition to these ongoing Phase 3 studies, the companies in question are also exploring the drug in Phase 1 and 2 clinical development trials for several other tumor types.</p><p>In the end, if Perifosine proves to be successful at treating multiple cancers, it will make a big splash in the field of medicine.  The return for AEZS will be substantial and as a result will move the stock price well north of its current value.</p><p>Titan Pharmaceuticals, Inc. (<a href="http://seekingalpha.com/symbol/ttnp.ob?source=search_general&amp;s=ttnp.ob">TTNP.OB</a>) is a biopharmaceutical company that develops therapeutics primarily for the treatment of central nervous system disorders and opioid addiction.  That might sound like a weird pairing but it just might prove to be a winning combination.  First, the company offers Fanapt, which is for the treatment of adult patients with schizophrenia.   The drug was approved by the U.S. FDA on May 6, 2009 and Novartis (<a href='http://seekingalpha.com/symbol/nvs' title='Novartis AG'>NVS</a>)  has licensed the rights to commercialize Fanapt in the U.S. and Canada, and commenced marketing the product in the U.S. in Q1, 2010. Titan is entitled to receive royalties on global net sales of Fanapt equal to 8% on annual net sales up to $200 million, and 10% on annual net sales above $200 million for the life of the licensed patents. Net sales of Fanapt by Novartis during the three-month period ended June 30 and 2010 were approximately $7.5 million and $0.7 million, respectively, and TTNP was obligated to pay royalties of approximately $1.1 million and $0.1 million to Sanofi-Aventis (<a href='http://seekingalpha.com/symbol/sny' title='sanofi-aventis'>SNY</a>) on June 30 and 2010.  Once again this is a nice revenue stream for the company but not enough to take the share price to the lofty heights our basket needs.</p><p>Now consider Probuphine, which is in Phase III clinical trials for the treatment of opioid addiction. Worldwide, it is estimated that there are 6 million opioid addicts. Approximately one-half of this potential patient population is addicted to illicit opioids, such as heroin, and the other half to prescription drugs, such as oxycontin, methadone, and codeine. As of 2002, physicians can be certified to prescribe opioid addiction medications in an office setting, which has greatly expanded patient access to opioid addiction pharmaceutical therapies. Currently, there are more than 750,000 people globally receiving medicinal treatment for opioid addiction.  The market for such a product is large.  Worldwide, sales for oipioid addiction treatments were $1.1 billion in 2009 and approximately $900 million of these sales were in the United States. Since the drugs U.S. approval in 2002, the number of doctors certified to prescribe these drugs has grown to approximately 20,000 in 2010.</p><p>RXi Pharmaceuticals Corporation (<a href="http://seekingalpha.com/symbol/rxii?source=search_general&amp;s=rxii">RXII</a>) is another biotechnology company that has the potential to be part of the basket. What RXII brings to the table is its lead product candidate, NeuVax.  This product stimulates T cells in a highly specific manner to target cells associated with breast cancer. With over 200,000 women in the U.S. diagnosed with breast cancer annually, the market for RXII would be huge.  Based on a successful Phase II trial, the FDA granted a Special Protocol Assessment for the Phase III study. This Phase III multicenter trial is expected to commence in the first half of 2012.  If NeuVax is as good as the company suggests, the price per share will move to a much higher level than where it trades today.  Before it becomes a contender, one should check the most recent financial reports.</p><p>As of June 30, cash, cash equivalents and short-term investments totaled $17.9 million, compared with cash and cash equivalents of $6.9 million at December 31, 2010. This $11.0 million increase is attributable to the closing of two underwritten public offerings that provided net cash proceeds of $18.2 million after fees, offset by net cash used in operating activities of $7.2 million for the six months ended June 30.  The research and development expenses increased to $2.7 million in the second quarter of 2011 from $2.3 million in the second quarter of 2010, and increased to $4.8 million for the first six months of 2011 from $4.2 million for the first six months of 2010. The increase was primarily due to an increase in research and development cash expenses due to a ramp-up in NeuVax. The question will be if RXII has enough cash to burn as RXII conducts the Phase III trials.  </p><p>Novavax, Inc. (<a href="http://seekingalpha.com/symbol/nvax?source=search_general&amp;s=nvax">NVAX</a>) could be another candidate for the basket.  NVAX is a clinical-stage biopharmaceutical company focusing on developing recombinant vaccines for infectious diseases using its virus-like particle platform technology. Its vaccine product candidates target pandemic influenza, (including H1N1 and H5N1 strains), seasonal influenza, Respiratory Syncytial Virus, and Varicella Zoster Virus that causes shingles. The company has a joint venture with Cadila Pharmaceuticals Ltd. to develop and commercialize seasonal influenza and H1N1 pandemic vaccine candidates for the territory of India. It also has a co-marketing agreement with <a href='http://seekingalpha.com/symbol/ge' title='General Electric Company'>GE</a> Healthcare for a pandemic influenza vaccine solution.</p><p>NVAX might make an interesting choice as new warnings are popping up about new cases of flu oversees.  If any of these reports were to turn into a real worldwide concern, NVAX could find itself and its products pushed to the front line of the war on the pandemic.  The share price would increase on a rapid scale.  In the meantime, investors will have to focus on Novavax&rsquo;s financial reports.   Novavax reported a net loss of $5.0 million, or $0.04 per share, for the second quarter of 2011 compared to a net loss of $8.9 million, or $0.09 per share, for the second quarter of 2010. For the six months ended June 30, the net loss was $12.4 million, or $0.11 per share, compared to a net loss of $19.2 million, or $0.19 per share, for the same period in 2010. The primary reason for the decreased loss for the second quarter of 2011 as compared to the same period in 2010 was higher revenue associated with the company's activities under its contract with the Office of Biomedical Advanced Research and Development Authority within the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, awarded in February, as well as lower research and development spending to support the company's clinical trials related to its vaccine candidates.</p><p>Research and development expenses for the second quarter of 2011 were $5.6 million as compared to $6.3 million in the same period in 2010. General and administrative expenses were $3.3 million for the second quarter of 2011 as compared to $3.1 million in the same period in 2010.</p><p>As of June 30, the company had $22.3 million in cash, cash equivalents and short-term investments compared to $31.7 million as of December 31, 2010.</p><p>MannKind Corporation (<a href="http://seekingalpha.com/symbol/mnkd?source=search_general&amp;s=mnkd">MNKD</a>) is another example of a perfect stock that could be part of the basket.  MNKD's  going to be a high risk/high reward type equity that brings the volatility that is needed.  MNKD is a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer. The lead product MNKD's trying to bring to market is Afrezza, which is rapid acting insulin that has completed Phase 3 clinical trials for the treatment of diabetes. If ever approved, this would be a game changer for MannKind and for diabetes patients as well.  This drug can be inhaled, which is a better prospect for patients than treatments with needles.  The downside is that the company has had two rejected applications to the FDA to sell the product. The company received two response letters (CRLs) regarding its insulin platform from the U.S. FDA, in March 2010 and in January 2011. The problem is that as the FDA asks for more information, it delays any chance for a revenue stream in the near future.  As Mannkind addresses the FDA&rsquo;s concerns, the delay is bleeding cash.  As of June, the company had approximately $24.7 million left with a burn rate that will eat that balance up in short order. </p><p>Here is the good news.  The FDA has not written off MNKD and there is still a good chance that approval will happen.  The trials to get to the results will probably not be completed until late 2012 or into 2013.  The concept for inhalable insulin is going to be a winner if the company can get by the FDA.  Anyone who has diabetes and is eligible for the product will probably switch over from using the needles rather quickly. MNKD's share price will be at a much different level if and when that happens.  In the meantime a partner or joint venture  can always materialize which could bolster the company's strapped cash issue. </p><p>It would be hard to imagine a basket of speculative healthcare stocks without a mention of Geron (<a href="http://seekingalpha.com/symbol/gern?source=search_general&amp;s=gern">GERN</a>).  GERN is a biopharmaceutical company that develops biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, and diabetes. GERN actually has a pretty deep pipeline and has multiple Phase 2 trials dealing with cancer therapies.  That being the case, the real catalyst for the company is the Phase 1 clinical trial dealing with treatment of spinal cord injuries with stem cells.  Regenerative medicine could prove to be the next big leap in medicine, and if it does  happen, GERN will be one of the companies on the tip of the spear.  What is interesting about this company is that GERN's stem cell trial is attempting to tackle spinal cord injuries. The spinal cord is one of the most complex parts of the human body.  Any success here will make GERN and its stock move to a different level.  The initial human trials are well underway and the test subject has not shown any adverse effects from the treatments. In May, the study added a second subject as part of the trail so the process is moving forward. It remains to be seen how long the trials will go and how successful they might be.</p><p>GERN reported cash, cash equivalents and marketable securities at June 30 were $192.2 million, compared to $221.3 million at December 31, 2010.  The company also stated that this cash reserve plus the income GERN receives will be sufficient to fund the current level of operations through at least December 2012. GERN also states that future capital requirements will be substantial as several trials are moving forward, yet another example of a high risk/high reward stock that might fit well into the basket.</p><p>This  is by no means a recommendation which should be copied and blindly invested in.  To put together a basket, one needs to truly dig deep into each potential candidate company.  Skimming an article or two on a financial website is a good start but cannot be deemed a viable substitute for reading SEC filings, listening to conference calls, and viewing company presentations.  There are critical questions that must be answered before any stock is allowed into the basket.  </p><p><strong>Disclosure: </strong>I am long <a href="http://seekingalpha.com/symbol/kerx">KERX</a>, <a href="http://seekingalpha.com/symbol/rxii">RXII</a>.</p>
          <script type="text/javascript">SeekingAlpha.Initializer.LogAndRun(load_article_toolbar);</script>
          
        </div>

        <div id="content_follow_up">
          <div id="follow_wrap">
            
              <div class="tagged_with">
                <span class="tagged_with_label">This article is tagged with: </span> <a href='/dashboard/investing_ideas' sasource='article_navigation'>Long &amp; Short Ideas</a>, <a href='/articles?filters=quick-picks-lists' sasource='article_navigation'>Quick Picks &amp; Lists</a>
              </div>
              <script type="text/javascript">
                news_beat_sections += ",Long & Short Ideas,Quick Picks & Lists"
              </script>
            

            
              <div class="more_by_auth">
                <a class="more_by_auth_img" href="/author/michael-j-ray"><img align="center" width="20" height="20" src="http://static.seekingalpha.com/images/users_profile/000/937/478/big_pic.png?1308631716" alt="Michael J. Ray picture"/></a>
                More articles by <a class="more_by_auth_name" href="/author/michael-j-ray/articles" sasource="more_au_link">Michael J. Ray &raquo;</a>
                <div id="content_bottom_more_by_articles">
                  <ul>
                    
                      <li>
                        <a href="/article/291693-mlp-closed-end-funds-proceed-with-caution" sasource="more_au_1" >MLP Closed End Funds: Proceed With Caution</a>
                        <span style="white-space:nowrap">Today</span>
                      </li>
                    
                      <li>
                        <a href="/article/290642-china-vs-united-states-war-of-the-oil-sands" sasource="more_au_2" >China Vs. United States: War Of The Oil Sands</a>
                        <span style="white-space:nowrap">Tue, Aug 30</span>
                      </li>
                    
                      <li>
                        <a href="/article/290355-tax-free-investing-using-closed-end-funds" sasource="more_au_3" >Tax-Free Investing Using Closed-End Funds</a>
                        <span style="white-space:nowrap">Mon, Aug 29</span>
                      </li>
                    
                  </ul>
                </div>
              </div>
            

            <script src="http://static.seekingalpha.com/javascripts/aScroll.js?1310882700" type="text/javascript"></script>
<div id="scroller_info" style="display:none">
  

  
    <div>
      <div class="also_like_user_cnt also_like_1">
        
        <a sasource="aal_1_ti" href="/article/290238-add-questcor-to-your-diversified-high-growth-biotech-portfolio" class="also_like_commenter also_like_link_img_1">
          <img alt="" class="also_like_img_1" src="http://static.seekingalpha.com/images/users_profile/000/759/138/big_pic.png?1296181437"/>
        </a>
        <a sasource="aal_1_ti" href="/article/290238-add-questcor-to-your-diversified-high-growth-biotech-portfolio" class="also_like_user_desc also_like_link_1" title="Add Questcor To Your Diversified High-Growth Biotech Portfolio">
          Add Questcor To Your Diversified High-Growth Biotech Portfolio
        </a>
        <p class="also_like_user_date also_like_date_1">Sun, Aug 28</p>
        <p class="also_like_user_by also_like_author_name_1">by <a href="/author/james-stocklasar-thomas-jr" sasource="aal_1_ti">James Stocklasar Thomas Jr.</a></p>
      </div>
    
    
  
    
      <div class="also_like_user_cnt also_like_2">
        
        <a sasource="aal_2_ti" href="/article/288822-aeterna-zentaris-the-very-best-biotech-under-2" class="also_like_commenter also_like_link_img_2">
          <img alt="" class="also_like_img_2" src="http://static.seekingalpha.com/images/users_profile/000/759/138/big_pic.png?1296181437"/>
        </a>
        <a sasource="aal_2_ti" href="/article/288822-aeterna-zentaris-the-very-best-biotech-under-2" class="also_like_user_desc also_like_link_2" title="AEterna Zentaris: The Very Best Biotech Under $2">
          AEterna Zentaris: The Very Best Biotech Under $2
        </a>
        <p class="also_like_user_date also_like_date_2">Mon, Aug 22</p>
        <p class="also_like_user_by also_like_author_name_2">by <a href="/author/james-stocklasar-thomas-jr" sasource="aal_2_ti">James Stocklasar Thomas Jr.</a></p>
      </div>
    
    
  
    
      <div class="also_like_user_cnt also_like_3">
        
        <a sasource="aal_3_sc1" href="/article/291731-nike-under-armour-battle-rages-as-back-to-school-sales-impress" class="also_like_commenter also_like_link_img_3">
          <img alt="" class="also_like_img_3" src="http://static1.seekingalpha.com/images/users_profile/000/652/617/big_pic.png?1274324263"/>
        </a>
        <a sasource="aal_3_sc1" href="/article/291731-nike-under-armour-battle-rages-as-back-to-school-sales-impress" class="also_like_user_desc also_like_link_3" title="Nike, Under Armour Battle Rages As Back-To-School Sales Impress ">
          Nike, Under Armour Battle Rages As Back-To-School Sales Impress 
        </a>
        <p class="also_like_user_date also_like_date_3">Today</p>
        <p class="also_like_user_by also_like_author_name_3">by <a href="/author/jefferson-starship" sasource="aal_3_sc1">Jefferson Starship</a></p>
      </div>
    
    
  
    
      <div class="also_like_user_cnt also_like_4">
        
        <a sasource="aal_4_sc25" href="/article/291178-6-stocks-that-can-make-money-in-a-low-growth-environment" class="also_like_commenter also_like_link_img_4">
          <img alt="" class="also_like_img_4" src="http://static.seekingalpha.com/images/users_profile/000/110/260/big_pic.png?1234098648"/>
        </a>
        <a sasource="aal_4_sc25" href="/article/291178-6-stocks-that-can-make-money-in-a-low-growth-environment" class="also_like_user_desc also_like_link_4" title="6 Stocks That Can Make Money In A Low Growth Environment">
          6 Stocks That Can Make Money In A Low Growth Environment
        </a>
        <p class="also_like_user_date also_like_date_4">Thu, Sep  1</p>
        <p class="also_like_user_by also_like_author_name_4">by <a href="/author/atticvs-research" sasource="aal_4_sc25">Atticvs Research</a></p>
      </div>
    
    
      </div>
      
    
  
    <div>
      <div class="also_like_user_cnt also_like_5">
        
        <a sasource="aal_5_ti" href="/article/287381-the-two-very-best-biotechs-under-3" class="also_like_commenter also_like_link_img_5">
          <img alt="" class="also_like_img_5" src="http://static.seekingalpha.com/images/users_profile/000/759/138/big_pic.png?1296181437"/>
        </a>
        <a sasource="aal_5_ti" href="/article/287381-the-two-very-best-biotechs-under-3" class="also_like_user_desc also_like_link_5" title="The Two Very Best Biotechs Under $3">
          The Two Very Best Biotechs Under $3
        </a>
        <p class="also_like_user_date also_like_date_5">Mon, Aug 15</p>
        <p class="also_like_user_by also_like_author_name_5">by <a href="/author/james-stocklasar-thomas-jr" sasource="aal_5_ti">James Stocklasar Thomas Jr.</a></p>
      </div>
    
    
  
    
      <div class="also_like_user_cnt also_like_6">
        
        <a sasource="aal_6_ti" href="/article/285745-top-buy-and-sell-ideas-from-last-week-s-big-biotech-movers" class="also_like_commenter also_like_link_img_6">
          <img alt="" class="also_like_img_6" src="http://static1.seekingalpha.com/images/users_profile/000/891/106/big_pic.png?1301054431"/>
        </a>
        <a sasource="aal_6_ti" href="/article/285745-top-buy-and-sell-ideas-from-last-week-s-big-biotech-movers" class="also_like_user_desc also_like_link_6" title="Top Buy and Sell Ideas From Last Week's Big Biotech Movers">
          Top Buy and Sell Ideas From Last Week's Big Biotech Movers
        </a>
        <p class="also_like_user_date also_like_date_6">Mon, Aug  8</p>
        <p class="also_like_user_by also_like_author_name_6">by <a href="/author/ganaxi-small-cap-movers" sasource="aal_6_ti">Ganaxi Small Cap Movers</a></p>
      </div>
    
    
  
    
      <div class="also_like_user_cnt also_like_7">
        
        <a sasource="aal_7_ti" href="/article/283420-revisiting-6-speculative-biotech-stocks-that-hedge-funds-love" class="also_like_commenter also_like_link_img_7">
          <img alt="" class="also_like_img_7" src="http://static.seekingalpha.com/images/users_profile/000/866/645/big_pic.png?1306309080"/>
        </a>
        <a sasource="aal_7_ti" href="/article/283420-revisiting-6-speculative-biotech-stocks-that-hedge-funds-love" class="also_like_user_desc also_like_link_7" title="Revisiting 6 Speculative Biotech Stocks That Hedge Funds Love">
          Revisiting 6 Speculative Biotech Stocks That Hedge Funds Love
        </a>
        <p class="also_like_user_date also_like_date_7">Sun, Jul 31</p>
        <p class="also_like_user_by also_like_author_name_7">by <a href="/author/nakedvalue" sasource="aal_7_ti">NakedValue</a></p>
      </div>
    
    
  
    
      <div class="also_like_user_cnt also_like_8">
        
        <a sasource="aal_8_ti" href="/article/278882-hunting-for-the-next-dendreon" class="also_like_commenter also_like_link_img_8">
          <img alt="" class="also_like_img_8" src="http://static.seekingalpha.com/images/users_profile/000/937/478/big_pic.png?1308631716"/>
        </a>
        <a sasource="aal_8_ti" href="/article/278882-hunting-for-the-next-dendreon" class="also_like_user_desc also_like_link_8" title="Hunting for the Next Dendreon">
          Hunting for the Next Dendreon
        </a>
        <p class="also_like_user_date also_like_date_8">Mon, Jul 11</p>
        <p class="also_like_user_by also_like_author_name_8">by <a href="/author/michael-j-ray" sasource="aal_8_ti">Michael J. Ray</a></p>
      </div>
    
    
      </div>
      
    
  
    <div>
      <div class="also_like_user_cnt also_like_9">
        
        <a sasource="aal_9_sc1" href="/article/291174-2-great-plays-in-sugarcane-ethanol" class="also_like_commenter also_like_link_img_9">
          <img alt="" class="also_like_img_9" src="http://static2.seekingalpha.com/images/users_profile/000/666/059/big_pic.png?1275994853"/>
        </a>
        <a sasource="aal_9_sc1" href="/article/291174-2-great-plays-in-sugarcane-ethanol" class="also_like_user_desc also_like_link_9" title="2 Great Plays In Sugarcane Ethanol">
          2 Great Plays In Sugarcane Ethanol
        </a>
        <p class="also_like_user_date also_like_date_9">Thu, Sep  1</p>
        <p class="also_like_user_by also_like_author_name_9">by <a href="/author/investment-u" sasource="aal_9_sc1">Investment U</a></p>
      </div>
    
    
  
    
      <div class="also_like_user_cnt also_like_10">
        
        <a sasource="aal_10_sc1" href="/article/291139-how-to-profitably-invest-in-solar-today" class="also_like_commenter also_like_link_img_10">
          <img alt="" class="also_like_img_10" src="http://static1.seekingalpha.com/images/users_profile/000/814/889/big_pic.png?1294324573"/>
        </a>
        <a sasource="aal_10_sc1" href="/article/291139-how-to-profitably-invest-in-solar-today" class="also_like_user_desc also_like_link_10" title="How To Profitably Invest In Solar Today">
          How To Profitably Invest In Solar Today
        </a>
        <p class="also_like_user_date also_like_date_10">Thu, Sep  1</p>
        <p class="also_like_user_by also_like_author_name_10">by <a href="/author/dana-blankenhorn" sasource="aal_10_sc1">Dana Blankenhorn</a></p>
      </div>
    
    
  
    
      <div class="also_like_user_cnt also_like_11">
        
        <a sasource="aal_11_sc1" href="/article/291093-2-bakken-explorers-that-could-yield-big-returns" class="also_like_commenter also_like_link_img_11">
          <img alt="" class="also_like_img_11" src="http://static1.seekingalpha.com/images/users_profile/000/022/392/big_pic.png?1261657267"/>
        </a>
        <a sasource="aal_11_sc1" href="/article/291093-2-bakken-explorers-that-could-yield-big-returns" class="also_like_user_desc also_like_link_11" title="2 Bakken Explorers That Could Yield Big Returns">
          2 Bakken Explorers That Could Yield Big Returns
        </a>
        <p class="also_like_user_date also_like_date_11">Thu, Sep  1</p>
        <p class="also_like_user_by also_like_author_name_11">by <a href="/author/david-white" sasource="aal_11_sc1">David White</a></p>
      </div>
    
    
  
    
      <div class="also_like_user_cnt also_like_12">
        
        <a sasource="aal_12_sc2" href="/article/290960-biopharma-the-waiting-is-the-hardest-part" class="also_like_commenter also_like_link_img_12">
          <img alt="" class="also_like_img_12" src="http://static.seekingalpha.com/images/users_profile/000/937/478/big_pic.png?1308631716"/>
        </a>
        <a sasource="aal_12_sc2" href="/article/290960-biopharma-the-waiting-is-the-hardest-part" class="also_like_user_desc also_like_link_12" title="Biopharma: The Waiting Is The Hardest Part">
          Biopharma: The Waiting Is The Hardest Part
        </a>
        <p class="also_like_user_date also_like_date_12">Wed, Aug 31</p>
        <p class="also_like_user_by also_like_author_name_12">by <a href="/author/michael-j-ray" sasource="aal_12_sc2">Michael J. Ray</a></p>
      </div>
    
    
      </div>
      
    
  
</div>     
<div class="also_like_cnt" id="also_like_cnt">
  <h1>You may also like</h1>
  <div class="also_like_gallery_outer_cnt">
    <div id="alsoLike_arr_left" class="alsoLike_arr_left" onclick='slide_also_like.slideMove("left"); selected_page();updateSources();'></div>
    <div id="alsoLike_arr_right" class="alsoLike_arr_right" onclick='slide_also_like.slideMove("right"); selected_page();updateSources();'></div>
    <div class="also_like_gallery_cnt">
      <div id="also_like_slide" style="height:205px;" class="also_like_gallery_innner_cnt">
        <div isfull="true"></div>
        <div isfull="false"></div>
      </div>
    </div>
    <div id="also_like_slide_pagination" class="also_like_slide_pagination">
      <span style="cursor:pointer;" onclick="slide_also_like.setContentByIndex(0); selected_page();" class="selected"></span>
      <span style="cursor:pointer;" onclick="slide_also_like.setContentByIndex(1); selected_page();"></span>
      <span style="cursor:pointer;" onclick="slide_also_like.setContentByIndex(2); selected_page();"></span>
    </div>
  </div>
</div>
<script>

  
    var replace_indices = [1,2,5,6,7,8]
    var ticker_re = /(?:[?|&](?:s|symbol)=(gern|mnkd)|(?:stock|ticker|quotes?|fund|index)\/(gern|mnkd))/i;
    var res = ticker_re.exec(document.referrer);
    var ticker = res ? (res[1] || res[2]) : null;
    var also_like_by_ticker = {"mnkd":[["/article/290744-20-worst-performing-stocks-in-short-sellers-sights","ti","http://static2.seekingalpha.com/images/users_profile/000/666/527/big_pic.png?1276034570","20 Worst-Performing Stocks In Short-Sellers' Sights","Tue, Aug 30","by Kapitall"],["/article/290139-4-oversold-biotech-stocks-being-snapped-up-by-insiders","ti","http://static2.seekingalpha.com/images/users_profile/000/666/527/big_pic.png?1276034570","4 Oversold Biotech Stocks Being Snapped Up By Insiders","Fri, Aug 26","by Kapitall"],["/article/288471-12-cancer-stocks-being-snapped-up-by-insiders","ti","http://static2.seekingalpha.com/images/users_profile/000/666/527/big_pic.png?1276034570","12 Cancer Stocks Being Snapped Up by Insiders","Fri, Aug 19","by Kapitall"],["/article/288315-salvage-operations-in-the-biopharma-wreckage","ti","http://static.seekingalpha.com/images/users_profile/000/937/478/big_pic.png?1308631716","Salvage Operations in the Biopharma Wreckage","Thu, Aug 18","by Michael J. Ray"],["/article/288017-health-care-stock-watch-some-stocks-rebounding-some-not-so-much","ti","http://static2.seekingalpha.com/images/users_profile/000/252/848/big_pic.png?1307603003","Health Care Stock Watch: Some Stocks Rebounding, Some Not So Much","Wed, Aug 17","by VFC's Stock House"]],"gern":[["/article/290638-post-excessive-sell-off-september-is-still-in-the-wind","ti","http://static2.seekingalpha.com/images/users_profile/000/438/392/big_pic.png?1254930488","Post Excessive Sell-Off, September Is Still In The Wind","Tue, Aug 30","by Henry McCusker"],["/article/289977-6-healthcare-stocks-primed-for-a-rebound","ti","http://static2.seekingalpha.com/images/users_profile/000/252/848/big_pic.png?1307603003","6 Healthcare Stocks Primed For A Rebound","Fri, Aug 26","by VFC's Stock House"],["/article/289540-regenerative-medicine-companies-trading-at-huge-discounts","ti","http://static2.seekingalpha.com/images/users_profile/000/438/392/big_pic.png?1254930488","Regenerative Medicine Companies Trading At Huge Discounts ","Wed, Aug 24","by Henry McCusker"],["/article/289191-stocks-to-watch-this-week","ti","http://static2.seekingalpha.com/images/users_profile/000/252/848/big_pic.png?1307603003","Stocks To Watch This Week","Tue, Aug 23","by VFC's Stock House"],["/article/287479-a-few-more-health-care-companies-beat-down-with-the-market","ti","http://static2.seekingalpha.com/images/users_profile/000/252/848/big_pic.png?1307603003","A Few More Health Care Companies Beat Down With the Market","Mon, Aug 15","by VFC's Stock House"]]};
    var new_articles;
    if (ticker && (new_articles = also_like_by_ticker[ticker.toLowerCase()])) {
      var i = 0;
      new_articles.each(function(attr){replace_also_like(attr, replace_indices[i++])})
    } 
  
    function replace_also_like(attr, idx) {//attr: url, source, img, title, date, author_name
      $$('.also_like_link_img_' + idx).each(function(el){el.setAttribute('href', attr[0]);});
      $$('.also_like_link_img_' + idx).each(function(el){el.setAttribute('sasource', 'aal_' + idx + '_' + attr[1]); });
      $$('.also_like_img_' + idx).each(function(el){el.setAttribute('src', attr[2]);});
      $$('.also_like_link_' + idx).each(function(el){el.innerHTML = attr[3];});
      $$('.also_like_link_' + idx).each(function(el){el.setAttribute('href', attr[0]);});
      $$('.also_like_link_' + idx).each(function(el){el.setAttribute('sasource', 'aal_' + idx + '_' + attr[1])});
      $$('.also_like_date_' + idx).each(function(el){el.innerHTML = attr[4];});
      $$('.also_like_author_name_' + idx).each(function(el){el.innerHTML = attr[5];});
    }
  

  var elArray = $("scroller_info");
  elArray = elArray.childElements();
  var slide_also_like = new aScroll('also_like_slide',432,elArray);
  var current_page = 0;

  function selected_page(){
    var new_page = 0;
    $('also_like_slide_pagination').select("span").each(function(value){
    if (new_page == slide_also_like.currentIndex){
      value.className = "selected";
    }
    else{
      value.className = "";
    }
    new_page++;
    })
  }
  
  function updateSources(){ // part of AB testing for slider location
    var source_extra = (typeof sasource_extras && typeof selectPosition != "undefined" && typeof already_open != "undefined" && already_open == true) ? "_" + selectPosition.toLowerCase() : "";
    if (source_extra != ""){
      sasource_extras('also_like_cnt', '_'+selectPosition.toLowerCase());    
    }
  }
</script>
          
            <div class="share_this_page_article_bottom">
               <ul id="page_toolbar">
  
  
	<li class="share_this_page_article_toolbar">
		<div class="recommend_link" onclick="pop_recommendation('/article/291745-gambling-with-speculative-healthcare-stocks', true, 291745, 1, 'default')">
	Recommend
</div>
<div class="recommend_num" onclick="pop_recommendation('/article/291745-gambling-with-speculative-healthcare-stocks', true, 291745, 1, 'default')">
	<span class="recommends_box text">0</span>
	<span class="right_close"></span>
</div>
		

<div class="share_this_page_snippet">
  <h6>Share this page</h6>
  <div class="widgets">
    
    <!-- facebook -->
    <span class="facebook_small"><a class="fb_link_button_count" name="fb_share" type="button_count" href="http://www.facebook.com/sharer.php" onclick="open_facebook()"><span class="share_text_fb">Share</span></a></span>
    <script>SeekingAlpha.Initializer.AddAfterLoad(init_facebook);</script>
    
      <span id="linkedin_2" class="linkedin_small"><script type="IN/Share" data-counter="right"></script></span>
      
    
    <!-- twitter -->
    <span class="twitter_small">
    <script type="text/javascript">tweetmeme_style = 'compact';</script>
    <script>
      twittememeFrame(window.tweetmeme_style== "compact" ? "85x20": "50x61");
    </script>
    </span>
  </div>
  
</div>
	</li>
</ul>
            </div>
            <div class="cleaner"></div>
            <ul class="bottom_print_email_links">
<li class="email">
  <span class="text" onmouseover="this.style.textDecoration='underline'" onmouseout="this.style.textDecoration='none'" onclick="email_story_to_friends('Article',291745,'http://seekingalpha.com/article/291745-gambling-with-speculative-healthcare-stocks')">Email</span>
</li>
<li onclick="print_article('with_comments')" class="print">
  <div class="text" onmouseover="this.style.textDecoration='underline'" onmouseout="this.style.textDecoration='none'">Print</div>
</li>

</ul>

            
            
          </div>
          <div class="comments_with_more">
            <script>
  top_commenters_array = [480016,353732,181517,265539,269895,228383,192595,232119,227454,411333,283977,428250,423259,591536,314511,223670,372226,56572,317799,399221,84036,393700,157675,341510,351063,595199,366570,407380,492600,98115,343824,386082,524234,605212,259051,270150,269624,420242,162115,432123,531750,182679,357305,198185,226535,195387,469451,142982,525333,53773,232981,336334,314687,290630,267315,329713,252337,352148,226469,68061,360479,337397,166473,419071,206391,104018,473496,329934,364357,718023,213514,577924,236295,764315,239719,333610,436500,361466,27285,491006,387543,206839,368181,591388,379514,812815,315437,269553,365501,204402,526829,261569,362139,240305,190116,414231,312209,173432,274708,380678];
</script>
<div id='comments'><a name="comments_header"></a>


  
  <div class="comments_top_area">
    <div class="comments_top_area_half">
      <div class="comments_top_area_add"><strong>Comments</strong> (<span id="comments_count_container">0</span>)</div>
      <div class='be_the_first' id='be_the_first_note'>Be the first to comment on this article</div>
      <div class="cleaner"></div>
    </div>
    <div>
        <a onclick="open_immediate_comment_box();" class="add_a_comment_link">Add a comment</a>
      <div class="comments_top_track">
        
          <div id="tracking_container"></div>
          <script>
          var params = {'post_id': 291745, 'total_comments': '0', 'author_user_id': '937478'}
            new Ajax.Request('/articles/enqueue_tracking', {
              parameters: params,
              onSuccess: function(response) {
                $('tracking_container').innerHTML = response.responseText;
              },
              onFailure: function() {
              }
            });
          </script>
        
      </div>
      
      <div class="cleaner"></div>
    </div>
  </div>



<div id="notice_wrapper_comments_list" class="notice_message"><span id="notice_comments_list"></span></div><script type='text/javascript'>SeekingAlpha.Initializer.LogAndRun(function () { notice_to_element("comments_list","update"); })</script>
<ul id="talkback_list">
  
</ul>
<div id="continue_load_comments" class="continue_load_comments_button" style="display:none;" onclick="continue_loading_comments();">
	<div class="l"></div>
  <div class="c">Load All Comments</div>
  <div class="r"></div>
</div>
<div id="comment_form_wrapper">
  


<div id="comment_form_Article_291745">
  
<script>
  reply_to_comment('Article_291745',"")
</script>

</div>

<script type="text/javascript">
function getSpellCheckArray() { 
  return [[document,"comment_form_txtar"]];
}
SeekingAlpha.Initializer.AddAfterLoad(function () { jspellInit(); });
</script>

  <div class='cleaner'></div></div>
</div>

<script>mark_new_comments_if_tracking_source();</script>

          </div>
          
          <div class="cleaner"></div>
          <span class="article_submit_an_article_big" onclick="if (!is_users_cookie_exists()) { open_header_log_in_popup_lightbox('write_post','submit an article') } else {top.location.href='/account/write_post'}"></span>
        </div>      
      </div>
      
      <div id="secondary_ads" class="no_big_gaps_secondary_ads" style="float:right;">
        <div id="author_avatar">
  
    <div class="follow_sidebar">
      <div id="author_info"> 
  
  
    <script>
      var author_info_popup_timeout;
      function ShowAuthorInfo(){
        if (author_info_popup_timeout) clearTimeout(author_info_popup_timeout);
        $('article_author_info').style.display = "block";
      }
      function HideAuthorInfo(){
        author_info_popup_timeout = setTimeout(function() {
          $('article_author_info').style.display="none";},400);
        }
      function clearAuthorInfoPopupTimeout(){
  	    if (author_info_popup_timeout) clearTimeout(author_info_popup_timeout);
      }
    </script>
  
  <div class="author_page_tools" id="author_image_header">
    
    
      
    
    <div  style="position:relative;float:left">
      <div id="goto_edit_picture" class="goto_edit_picture" ><span onclick="return goto_update_picture();" onmouseover="ShowAuthorInfo();" onmouseout="HideAuthorInfo();"></span></div>
      <a href="/author/michael-j-ray"  class='this_is_a_author_pic' sasource="about_lpic"><img class="this_is_a_author_pic_img" align="center" src="http://static.seekingalpha.com/images/users_profile/000/937/478/big_pic.png?1308631716" alt="Michael J. Ray picture" onmouseover="ShowAuthorInfo();" onmouseout="HideAuthorInfo();" /></a>
      
        <div id="article_author_info" style="display:none;" onmouseover="clearAuthorInfoPopupTimeout();" onmouseout="HideAuthorInfo();">
          <div>
            <div class="followup_contributor_info">
  <div class="followup_contributor_info_title">
    <span>About the author: </span>
    <a href="/author/michael-j-ray" sasource="about_name">Michael J. Ray</a>
  </div>

  <div class="followup_contributor_info_on_author">
    <div class="followup_contributor_info_pic_cont">
      <div class="pic_cont">
        <div class="pic_contributor">
          <div class="the_pic">
              <a href="/author/michael-j-ray" sasource="about_pic"><img align="center" width="54" height="54" src="http://static.seekingalpha.com/images/users_profile/000/937/478/big_pic.png?1308631716" alt="Michael J. Ray picture"/></a>

          </div>
        </div>
      </div>
    </div>
    <div class="followup_contributor_info_text">
      An investor who watches and tracks trends and uses options to hedge the risk. I run a balanced portfolio which contains both growth and income related securities.
    </div>
    <div class="cleaner"></div>
	</div>
  <div class="followup_contributor_info_bottom_cnt">
    
    <div class="left_cnt">
      
    </div>
  </div>

  <div class="cleaner"></div>
</div>
<div class="followup_contributor_info_on_author_bottom"></div>
          </div>
        </div>
      
    </div>
    <a href="/author/michael-j-ray" class="author_info_name" sasource="about_lname">Michael J. Ray</a>
    <div class="cleaner"></div>
    
      <span class="leaders_link">
      <div class="author_info_opinion_leader">
        <ul class="opinion_leader_list">
          
            <li class="lead_top_num1"><div class="content">on <a href="/articles?filters=income-investing-strategy" sasource="author_id">Income Investing Strategy</a></div></li>
            
          
            <li class="lead_top_num5"><div class="content">on <a href="/articles?filters=closed-end-funds" sasource="author_id">Closed-End Funds</a></div></li>
            
          
        </ul>  
      </div>
      </span>  
    
    <div class="author_info_nav_border">
      <div class="author_info_nav">
        <ul class="the_author_info_nav">
          <li ><a href='/author/michael-j-ray/articles'>Articles <span>(41)</span></a></li>
          
            <li>
                   <a href='/author/michael-j-ray/instablog'>Instablog
                     <span>(2)</span>
                   </a>
                 </li>
            
            <li >
                   <a href='/author/michael-j-ray/recommendations'>Recommendations <span>(38)</span></a>
                 </li>
            <li >
                   <a href='/author/michael-j-ray/comments'>Comments <span>(78)</span></a>
                 </li>
            
              <script>if (/stats viewer/.test(readCookie("user_perm"))) document.write("<li><a href='/account/authorboard/earnings?for_user_id=937478'>Earnings</a></li>");</script>
            
          
          <li ><a href='/author/michael-j-ray'>Profile</a></li>
        </ul>
      </div>
    </div>
    <div class="cleaner"></div>
    <div class="user_followers_following">
      
      <div class="user_followers">
        <a href="/author/michael-j-ray/followers">
          <span id="followers" class="number followers_number_937478 followers_number_michael-j-ray">353</span>
          <span class="text">Followers</span>
        </a>
      </div>
      <div class="user_followers">
        <a href="/author/michael-j-ray/following">
          <span id="followings" class="number">34</span>
          <span class="text">Following</span>
        </a>
      </div>
    </div>

    <div id="follow_this_user" class="follow_this_user"></div>
    <script>Follow.author_sidebar__follow_button_initiator('michael-j-ray')</script>
    <span class='author_info_send_message' onclick='Messaging.sendMessage("byo6pt9v", "Article Author ID Card Upper")'>Send Message</span>
    <div class="cleaner"></div>
  </div>
  <div class="follow_popup_wrapper">
    
      <div class="green_pop_wrapper" id="stop_follow" style="display:none"><div class="green_pop_top_arrow"></div><div class="green_pop"><span class="close_pop" onclick="$('stop_follow').style.display='none'"></span><p>You are currently following Michael J. Ray</p><span class="stop_following" onclick="Follow.ajax_stop_follow_this_author(this, 'michael-j-ray')">Stop Following</span></div></div><div class="green_pop_wrapper" id="no_longer_follow" style="display:none"><div class="green_pop_top_arrow"></div><div class="green_pop"><span class="close_pop" onclick="$('no_longer_follow').style.display='none'"></span><p>You are no longer following Michael J. Ray</p></div></div>
    
  </div>
</div>

  <script>SeekingAlpha.Initializer.AddAfterLoad(function (){Follow.setFfToElements($('followers'),$('followings'),34673)})</script>

    </div>
    <div class="cleaner"></div>
    
  
</div>

        <a id="yahoo_finance_link" style="display: none" href="http://finance.yahoo.com"><img class="back_to_yahoo_finance" src="http://static.seekingalpha.com/images/back_to_yahoo_finance.png" alt="back to yahoo finance" /></a>

<script>
  source = getURLParam('source');
  if (source == 'yahoo') {
    $('yahoo_finance_link').style.display = 'block';
  }
</script>
        
          <div class="stickyad_wrapper">
            <div class="item banner160x600" id="fixed_banner160x600">
              <script type="text/javascript">
                iframeAd("160x600",'http://a.collective-media.net/adj/sek.target/article;sz=160x600;x=x;tile=3;d=target;t=article;d=investing-ideas;aid=291745;t=quick-picks-lists;t=sa-exclusive;a=michael-j-ray;s=aezs;s=ttnp.ob;s=rxii;s=nvax;s=mnkd;s=gern;'+dart_my_vocation_and_profiles()+'ord='+ord+'?"');
              </script>
            </div>
          </div>
        
      </div>
    </div>
    <div id="ads_and_tools">
  <div class="item banner300x600">
    <script>document.write('<scr'+'ipt language="JavaScript" type="text/javascript" src="http://a.collective-media.net/adj/sek.target/article;sz=300x250,300x600;x=x;tile=2;d=target;pos=t;t=article;d=investing-ideas;aid=291745;t=quick-picks-lists;t=sa-exclusive;a=michael-j-ray;s=aezs;s=ttnp.ob;s=rxii;s=nvax;s=mnkd;s=gern;'+dart_my_vocation_and_profiles()+'ord='+ord+'?"></scr'+'ipt>');</script>
  </div>
  <div id="alternative_title_container" class="mini_category data_currencies_table" style="display:none">
  <div class="red_title_bk">
    <span class="red_title_text" id="article_alternative_title"></span>			
  </div>
  <div id="symbol_alternative_tags" class="symbol_alternative_tags"></div>
  <script type="text/javascript">GA_googleFillSlot_sa("Article_120x30");</script>
  <div class="cleaner"></div>
</div>

<script type="text/javascript">
  symbol = "aezs";
  new Ajax.Request('/articles/get_ajax_alternatives_by_symbol?symbol='+symbol, {
    asynchronous:true,
    evalScripts:true,
    method:'get',
    onComplete: function(transport) {
      if (transport.status == 200 && transport.responseText != 'failed') {
        response = transport.responseText.split("@@");
        symbolZiignight = new Ziignight('', 'SAlternative',"","symbolZiignight","symbol_alternative_tags");
        symbolZiignight.WorkJSON = eval(response[1]);
        symbolZiignight.addETF = false;
        symbolZiignight.pageType = 'Article';
        symbolZiignight.selectedSymbol = symbol;
        symbolZiignight.SAlternativePrint(-1,true);
        symbolZiignight.InsertEtfAlternativeSymbol(response[0]);
        $('article_alternative_title').innerHTML = response[0].toUpperCase() + " vs. ETF Alternatives";
        $("alternative_title_container").style.display = "";
      }
    }
  });
</script>

  <div id="register_login_snippet"></div>
  
  <div id="side_customize" class="side_customize"></div>
  <div id="portfolio_form_box"></div>

  <div id="register_box"></div>
  <div id="article_sidebar" class="article_sidebar">
  <div id="article_sidebar_container"><img src="/images/loader_recommended_articles.gif" class="loader"/></div>
  <script>
    new Ajax.Request('/memcached/article_related_dashboards_sidebar', {
      method:'get',
      evalScripts:true,
      onSuccess: function(response) {
        var responsed = response.responseText;
        $('article_sidebar_container').innerHTML = responsed;
        responsed.evalScripts();
      },
      onFailure: function() {
      }
    });
  </script>
	<div class="cleaner"></div>
</div>

  <div id="articles_on_my_portfolio"></div>

    <script type="text/javascript">
      if (!is_users_cookie_exists()) {
        Authentication.RegisterBox("article_sidebar_advert_box", "redirecting_location", {Register:"Follow.RegisterBox"},"register_box","_box");
      }
    </script>
    <div class="cleaner"></div>
    <div class="stickyad_wrapper">
      <div class="item banner300x250" id="article_dart_sticky"></div>
    </div>
</div>
<script>
  var adInfo ={HadCreated:false, info:'http://a.collective-media.net/adj/sek.target/article;sz=300x250;x=x;tile=4;d=target;pos=b;t=article;d=investing-ideas;aid=291745;t=quick-picks-lists;t=sa-exclusive;a=michael-j-ray;s=aezs;s=ttnp.ob;s=rxii;s=nvax;s=mnkd;s=gern;'+dart_my_vocation_and_profiles()+'ord='+ord+'?"', size:'300x250'};
</script>

<script src="http://static.seekingalpha.com/javascripts/sa.js?1313932354" type="text/javascript"></script>
<script src="http://static.seekingalpha.com/javascripts/watchlist_management.js?1310882701" type="text/javascript"></script>
<script src="http://static.seekingalpha.com/javascripts/portfolio_form_popup_box.js?1313135920" type="text/javascript"></script>
  </div>
  <input id="short_url" type="hidden" value="http://seekingalpha.com/a/6941" />
  <div id="stickyside" class="close" style="display:none;">
    <div class="slide_shadow"></div>
    <div class="btn_open" onclick="sli.userMovement();"></div>
    <div class="btn_close" onclick="sli.pressedCloseButton();"></div>

    <div id="stickyside_btn" style="display:none" class="btn_close">xx</div>
    <div class="breaking_news_block content_slider_news_big" style="display:none;">
  <div class="slider_title"><span class="breaking_title">Breaking News</span> <span style="display:none" class="updated_time_ago_rightCnt">Updated at <span class="breaking_news_time"></span></span></div>
  <div class="breaking_news" id="breaking_news_wrap">
    <a class="breaking_news_number" href="/currents/all" sasource="bn_slider"></a>&nbsp;broke in the last few minutes - get the latest updates in <a href="/currents/all" sasource="bn_slider">Market Currents</a>.
  <span class="updated_time_ago">Updated at <span class="breaking_news_time"></span></span>
  </div>
</div>
  </div>
</div>
  <style>#footer_break_2{display:none}</style>
<div id='footer_break'><div></div></div>

<div id="footer">
  <div id="footernav">
    <div class="footernav_left">
      <a href="http://seekingalpha.com" class="footernav_logo"></a>
      <div class="footernav_boards">
        <div><span class="footer_title">TOP AUTHORS:</span>&nbsp;<a class="top_authors" href="/leader-board/opinion-leaders">The Opinion Leaders</a></div>
        <div class='top_boards'>
          <span class="footer_title">TOP USERS:</span>
          <a href="/leader-board/top-commenters">Commenters</a> <span class="fl_dash">|</span>
          <a href="/leader-board/top-stocktalkers">StockTalkers</a> <span class="fl_dash">|</span>
          <a href="/leader-board/top-instabloggers">Instabloggers</a>
        </div>    
      </div>
      <div class="cleaner"></div>
    </div>
    <div class="footernav_right">
      <div class="footernav_links">
        <a class="small_tweeter" target="_blank" href="http://twitter.com/seekingalpha">&nbsp;&nbsp;&nbsp; Twitter</a>
        <a class="small_rss" href="/page/feeds" sasource="footer">&nbsp;&nbsp;&nbsp;&nbsp;RSS Feeds</a>&nbsp;&nbsp;|&nbsp;
        <a href="/page/contact" sasource="footer">Contact Us</a>&nbsp;&nbsp;|&nbsp;
        <a href="/page/about_us" sasource="footer">About Us</a>&nbsp;&nbsp;|&nbsp;
        <a href="/premium-program/intro" sasource="footer">Premium Program</a>
      </div>
      
      <div class="footernav_more_links">
        <a href="/page/terms-of-use" sasource="footer">Terms of Use</a> |
        <a href="/page/privacy" sasource="footer">Privacy</a> |
        <a href="http://www.xignite.com" target="_blank">Xignite quote data</a> |
        <span>Copyright &#169; 2011</span>
      </div>
      
      <div class="cleaner"></div>
    </div>
   
  </div>
  <div id="footer_break_3"><div></div></div>
  <div class="cleaner"></div>
</div>



  <script type="text/javascript">
    
      SeekingAlpha.Initializer.onDOMLoad(function() { SA.Data.RecentQuotes.Add('aezs');});
      
    Event.observe(window, 'scroll', run_article_end_mone);
  
    $('stickyside_btn').className = "btn_open";

    var sli = new SideSlider('stickyside','right');    
    var already_open = false;
    function open_slide(){
      if (end_of_the_article() && sli && sli.eStatus=="close" && sli.shouldOpen(Breaking_News.currentNumber)){
        if (!already_open){
          console.log('go!');
          pageTracker._trackEvent('Article Tracking', 'MC Slider', 'Article');
        }
        already_open = true;
        sli.show();
        sli.autoMovement();
      }else{
        if (already_open && !end_of_the_article() && sli && sli.eStatus=="open"){
          sli.autoMovement();
        }
      }
    }
    screen.width>700 ? Event.observe(window, 'scroll', open_slide) : "";
    Breaking_News.getNumberOfNewCurrent();
  </script>

    <!-- ANALYTICS -->

 <script type="text/javascript">
  var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
  document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
</script>

<script type="text/javascript">
  try{
    var pageTracker = _gat._getTracker("UA-1466493-1");
    //pageTracker._setDomainName(".seekingalpha.com");

    (function(){
      //1 - foreign domain, 2 - whole path before '?', 3 - article's id, 4 - news-article id, 5 - instablog author id-slug, 6 - instablog id, 7 - title or anything else, 8 - ?..., 9 - #... (3,4,5+6 mutual exclusive)
      var urlRegExp = '^(?:https?://(?:(?:.+\\.)?seekingalpha.com|([^/]+)))?/((?:article/(\\d+)-|news-article/(\\d+)-|instablog/([^/]+)/(\\d+)-)?([^#?]*))(\\?[^#]*)?(#.*)?$';
      var m = document.referrer.match(urlRegExp), ref;
      if (m){
        if (m[1]) ref = m[1]+'/'+m[2];
        else if (m[3] && /transcript$/.test(m[7])) ref = 'article-trc';
        else if (m[3]) ref = 'article';
        else if (m[4]) ref = 'news-article';
        else if (m[5]) ref = 'instablog';
        else if (m[7]=='') ref = 'hp';
        else ref = m[7];

        //GA doesn't unescape custom vars on their side, so replacing to something that's not escaped
        pageTracker._setCustomVar(1, 'referrer', ref.replace(/\//g,'~').substr(0,54), 3);
      }

      
    })();

    pageTracker._setCustomVar(2, 'logged_in', (cookieExists('user_id') ? 'yes' : 'no'), 3);
    pageTracker._trackPageview(window._pageviewURL);
  } catch(err) {}
  
  urchinTracker = function(url) {
    try {
      pageTracker._trackPageview(url)
    } catch (err) {}
  };
  
  function trackLink(link, category, action, label) {
    try {
      pageTracker._trackEvent(category, action, label);
    }catch(err){}
  }  
</script>


<script type="text/javascript">
if(typeof (authors) == "undefined" || typeof (symbols) == "undefined")
	load_remote_script("/javascripts/sa.js");
</script>

<script src="http://static.seekingalpha.com/javascripts/jspellEvolution/jspellEvolution.js?1310882700" type="text/javascript"></script>
<script src="http://static.seekingalpha.com/javascripts/jspellEvolution/jspellSettings.js?1310882700" type="text/javascript"></script>
<script type="text/javascript">
  SeekingAlpha.Initializer.LogAndRun(gigyaSA.init);
  SeekingAlpha.Initializer.LogAndRun(LightBox.Init);
  SeekingAlpha.Initializer.LogAndRun(second_page_login_popup);

  SeekingAlpha.Initializer.Add(application_init);
	//SeekingAlpha.Initializer.AddAfterLoad($.jStorage._init);
  SeekingAlpha.Initializer.AddAfterLoad(user_profiles); 
  SeekingAlpha.Initializer.AddAfterLoad(Mone.touch());
  SeekingAlpha.Initializer.AddAfterLoad(function() {
    var source = window._saSource;

    if (source){
      var m = document.referrer.match(/^https?:\/\/(?:(?:.*\.)?seekingalpha.com|([^\/]+))(\/article\/\d+-|\/[^?#]*)/);
      var ref = m ? ((m[1] ? m[1] : '') + m[2]) : '';
      var event_data = null;
      if (source == 'salogo') event_data = ['headtabs', 'logo', ref];
      else if (source == 'headtabs') event_data = ['headtabs', location.pathname, ref];
      else if (source == 'footer') event_data = ['footer', location.pathname, ref];
      if (event_data) pageTracker._trackEvent(event_data[0], event_data[1], event_data[2]);
    }
  });

  SeekingAlpha.Initializer.Run();
</script>
<div id="symbol_data_script_container">
</div>  
<script type="text/javascript">
  var _sf_async_config={uid:23852,domain:"seekingalpha.com",authors:false};

  if(typeof(news_beat_sections) !== 'undefined') {
    _sf_async_config.sections = news_beat_sections;
  } else {
    _sf_async_config.sections = "N-A";
  }

  if(typeof(news_beat_author) !== 'undefined') {
    _sf_async_config.authors = news_beat_author;
  }

  (function(){
    function loadChartbeat() {
      window._sf_endpt=(new Date()).getTime();
      var e = document.createElement('script');
      e.setAttribute('language', 'javascript');
      e.setAttribute('type', 'text/javascript');
      e.setAttribute('src',(("https:" == document.location.protocol) ? "https://a248.e.akamai.net/chartbeat.download.akamai.com/102508/" : "http://static.chartbeat.com/") + "js/chartbeat.js?v=3");
      document.body.appendChild(e);
    }
    var oldonload = window.onload;
    window.onload = (typeof window.onload != 'function') ?
      loadChartbeat : function() { oldonload(); loadChartbeat(); };
  })();


<!-- Start Quantcast tag -->
_qoptions={
qacct:"p-36Zq38JCUmc3w"
};
</script>
<script type="text/javascript" src="https://secure.quantserve.com/quant.js"></script>
<noscript>
<img src="https://secure.quantserve.com/pixel/p-36Zq38JCUmc3w.gif" style="display: none;" border="0" height="1" width="1" alt="Quantcast"/>
</noscript>
<!-- End Quantcast tag -->

<!-- homepage event/user-guest/refresh-new checker starts -->
<script>if (/.com\/(\?.+)?$/.test(location.href)) { urchinTracker("event/home_page/" + (is_users_cookie_exists() ? "user" : "guest") + "/" + (isRefresh ? "refresh" : "new")) }</script>
<!-- homepage event/user-guest/refresh-new checker ends -->
<script type='text/javascript'>
try{if (window.Portfolio) Portfolio.fields.debt[4][1] = "Cash & Equivilants + MarketableSecurities (Short term Investments which will be liquidated within one year)"}catch(e){}
</script>

    <div class="cleaner"></div>
  </body>
</html>
